Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

An esketamine-based nasal spray antidepressant for adults is under review in the US following a filing from Johnson & Johnson's pharma unit. Janssen has submitted a filing for esketamine to the US ...

for SPRAVATO ® (esketamine) CIII nasal spray, making this innovative treatment the first and only monotherapy for adults living with major depressive disorder (MDD) who have had an inadequate ...

Esketamine (a derivative of ketamine) nasal spray formulations can act fast and help reduce dangerous symptoms of major depression and suicidal thoughts found a new study. The findings of this ...

We offer Spravato intranasal esketamine and intramuscular ketamine treatment therapy to patients in western North Carolina. Our mission is to help treat major depression, PTSD, and related anxiety ...

"A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants with ...